Picard Medical, Inc. (PMI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Picard Medical, Inc., a Delaware corporation, on November 26, 2025. The company is an emerging growth company with its principal executive offices in Tucson, Arizona. The report discloses a material event under Item 7.01 (Regulation FD Disclosure) regarding upcoming clinical data presentation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a specific event and does not contain financial statements or performance metrics.
Material Changes
There are no material changes to financial performance or operational status reported in this document. The primary disclosure is the announcement of a scheduled presentation of in vitro data for the Emperor Total Artificial Heart.
Outlook, Management Commentary, and Risks
- Upcoming Event: Duffy Elmer is scheduled to present in vitro data on the Emperor Total Artificial Heart at the 31st Annual Meeting of the International Society for Mechanical Circulatory Support.
- Event Details: The presentation will take place in Vienna, Austria, between December 1 and 4, 2025.
- Legal Disclaimer: The information in this report and its exhibits is not deemed "filed" under the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific details on the in vitro data.
- Monitor the proceedings of the 31st Annual Meeting of the International Society for Mechanical Circulatory Support (December 1-4, 2025) for the actual presentation.
- Review subsequent filings for any updates on the Emperor Total Artificial Heart development timeline or regulatory status.